TTK and cholangiocarcinoma: To explore whether the AKT and STAT3 signaling pathways were modulated by MPS1, CCA cells were pre-treated with siMPS1 followed by an AKT inhibitor (MK2206), an AKT activator (SC79), or a STAT3 inhibitor (Stattic).